YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

September 12, 2020

Study Completion Date

September 12, 2021

Conditions
Weight LossNAFLDLiver Diseases
Interventions
BEHAVIORAL

YMCA class

The Gastroenterologists of Weill Cornell Medical College that are associated with this trial want to implement the YMCA's DPP in the NAFLD population as a structured lifestyle modification/educational intervention. The hypothesis is that the NAFLD patients who complete the YMCA's DPP will also have weight loss and improvement in hepatic steatosis. Importantly, positive results in this New York City-based pilot study would provide a strong rationale for determining whether such a program could be useful to treat NAFLD at established YMCA DPP sites across the country.

Trial Locations (1)

10065

Weill Cornell Medical College, New York

All Listed Sponsors
collaborator

YMCA

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT03512184 - YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) | Biotech Hunter | Biotech Hunter